Track CTMX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
CTMX - CytomX Therapeutics Inc (CTMX) has a earnings per share of -$0.10, down 137.0% over the past year.
Latest EPS (Actual)
-$0.10
Beat Rate
62.5%
Most Recent
Meet
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.10 | -$0.10 | Meet | -2.88% |
| Mar 2026 | -$0.09 | -$0.22 | Miss | -134.79% |
| Nov 2025 | -$0.05 | -$0.09 | Miss | -80.00% |
| Aug 2025 | -$0.06 | -$0.00 | Beat | +98.00% |
| May 2025 | $0.13 | $0.27 | Beat | +104.24% |
| Mar 2025 | -$0.11 | $0.23 | Beat | +317.19% |
| Nov 2024 | -$0.17 | $0.07 | Beat | +141.18% |
| Aug 2024 | -$0.14 | -$0.08 | Beat | +42.86% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.